Tamarack Advisers, LP United Therapeutics Corp Transaction History

Tamarack Advisers, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$212.99 - $276.17 $1.28 Million - $1.66 Million	6,000 New	6,000 $1.34 Million
Q2 2022 Aug 16, 2022	BUY	$174.81 - $241.14 $5.24 Million - $7.23 Million	30,000 New	30,000 $7.07 Million
Q1 2022 May 11, 2022	SELL	$166.16 - $213.96 $2.49 Million - $3.21 Million	-15,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $9.22 Million - $10.8 Million	-50,000 Reduced 76.92%	15,000 $3.24 Million
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $539,580 - $644,640	3,000 Added 4.84%	65,000 $12 Million
Q2 2021 Aug 13, 2021	SELL	$170.47 - $211.93 $6.48 Million - $8.05 Million	-38,000 Reduced 38.0%	62,000 $11.1 Million
Q1 2021 May 12, 2021	SELL	$153.94 - $174.85 $12.8 Million - $14.5 Million	-83,000 Reduced 45.36%	100,000 $16.7 Million
Q4 2020 Feb 10, 2021	BUY	$101.87 - $151.79 $2.34 Million - $3.49 Million	23,000 Added 14.37%	183,000 $28.1 Million
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $1.5 Million - $1.82 Million	-15,000 Reduced 8.57%	160,000 $16.2 Million
Q2 2020 Aug 11, 2020	BUY	$92.74 - $125.82 $1.3 Million - $1.76 Million	14,000 Added 8.7%	175,000 $21.2 Million
Q1 2020 May 14, 2020	BUY	$79.39 - $115.35 $762,144 - $1.11 Million	9,600 Added 6.34%	161,000 $15.3 Million
Q4 2019 Feb 11, 2020	BUY	$78.31 - $95.34 $5.98 Million - $7.28 Million	76,400 Added 101.87%	151,400 $13.1 Million
Q3 2019 Nov 05, 2019	BUY	$74.85 - $85.99 $5.61 Million - $6.45 Million	75,000 New	75,000 $5.98 Million

723

60.9M

123K

104K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.